This study is looking at whether using an incentive spirometer, a device that helps you take deep breaths, can reduce lung problems in people with advanced non-small-cell lung cancer. These patients are also receiving chemotherapy and radiation therapy, and may receive immunotherapy. The study wants to see if using the spirometer 10 times every hour you're awake can lower the chance of developing lung inflammation (pneumonitis) and improve your overall survival and quality of life. You might be able to join if you have advanced non-small-cell lung cancer, are eligible for chemotherapy and radiation, and are at least 18 years old. The study will measure how many people develop pneumonitis within 12 months.

Study design

This is a pilot study involving 100 participants. It is an interventional study, meaning participants will receive a specific intervention.

What's involved

You will use an incentive spirometer 10 times every hour you are awake, daily during treatment and for up to three months after treatment. You will also complete quality of life assessments at the start, and at 3, 6, and 12 months.

Compensation

Not stated in the trial record.

Follow-up

The primary outcome, incidence of pneumonitis, will be measured at 12 months.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.